内江市 · 医药生物
汇宇制药 688553
Sichuan Huiyu Pharmaceutical Co., Ltd.
Since 2025, 汇宇制药 has published 4 hedging-related filings on cninfo, the most recent dated 2026-03-11. The full timeline is below; every entry links to the source document.
Instruments disclosed
FX 4
First appearance in this dataset: 2025-01-25
Disclosed products
唑来膦酸注射液、多西他赛注射液、奥沙利铂注射液、左乙拉西坦注射用浓溶液、普乐沙福注射液、注射用培美曲塞二钠
Position in the chain
Its products are not yet wired into the chain graph, so no neighbours are shown
Hedging filing timeline
2026
- FX Programme announcement
2025
- FX Feasibility report
- FX Policy document
- FX Programme announcement First
Every row above is a filing title and date published by the company itself. This site adds no interpretation, passes no judgement on the arrangements, and offers no investment advice. The filings on cninfo are authoritative.